The cost-effectiveness of neoadjuvant chemotherapy in women with locally advanced breast cancer: Adriamycin and cyclophosphamide in comparison with paclitaxel and gemcitabine
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.